| Literature DB >> 32908493 |
Rahmadewi Rahmadewi1, Retha Retha1, Dyah Ayu Pitasari1, Vidyani Adiningtyas Kusumastanto1, Agatha Anindita Ayu Ardhaninggar1, Irmadita Citrashanty1, Maylita Sari1, Menul Ayu Umborowati1, Cita Rosita Sigit Prakoeswa1.
Abstract
BACKGROUND: It is expected that a combination of amniotic membrane stem cell metabolite product (AMSC-MP) and vitamin E after fractional CO2 laser as laser-assisted drug delivery (LADD) will provide better effects in photoaging treatment as the combination reaches the target. This promises an option for photoaging therapy in the future.Entities:
Year: 2020 PMID: 32908493 PMCID: PMC7471827 DOI: 10.1155/2020/1584541
Source DB: PubMed Journal: Dermatol Res Pract ISSN: 1687-6113
Intragroup (the control group) result comparison (AMSC-MP with fractional laser CO2 as LADD).
| Observation no. | Wrinkle | UV spot | Polar spot | Pores |
|---|---|---|---|---|
| 1-2 | 0.515 | 0.332 | 0.014 | 0.251 |
| 2-3 | 0.077 | 0.538 | 0.003 | <0.001 |
| 1–3 | 0.131 | 0.168 | <0.001 | <0.001 |
Intragroup (the treatment group) result comparison (AMSC-MP + vitamin E with fractional laser CO2 as LADD).
| Observation no. | Wrinkle | UV spot | Polar spot | Pores |
|---|---|---|---|---|
| 1-2 | 0.492 | 0.888 | 0.001 | 0.285 |
| 2-3 | 0.246 | 0.140 | 0.403 | 0.362 |
| 1–3 | 0.831 | 0.050 | 0.003 | 0.920 |
A comparison between the control and treatment group.
| Obs | Wrinkles | UV spots | Polar spots | Pores | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMSC-MP | AMSC-MP + vit E |
| AMSC-MP | AMSC-MP + vit E |
| AMSC-MP | AMSC-MP + vit E |
| AMSC-MP | AMSC-MP + vit E |
| |
| 1 | 6.73 (2.58) | 7.17 (3.75) | 0.604 | 7.77 (3.59) | 6.93 (4.43) | 0.309 | 28.77 (6.53) | 28.77 (7.96) | 1 | 49.60 (4.92) | 49.60 (5.575) | 1 |
| 2 | 7.10 (2.98) | 7.97 (4.57) | 0.547 | 8.67 (5.12) | 7.67 (5.35) | 0.350 | 31.00 (6.22) | 32.03 (8.51) | 0.593 | 48.83 (4.95) | 50.17 (5.21) | 0.314 |
| 3 | 8.47 (4.48) | 7.03 (3.63) | 0.305 | 9.07 (5.23) | 9.27 (6.37) | 0.755 | 33.90 (6.37) | 31.13 (8.74) | 0.167 | 52.40 (5.34) | 49.53 (5.14) | 0.039 |
Figure 1A comparison of the first and second observations between the control (a) and treatment (b) groups.
Figure 2A comparison of the second and third observations between the control (a) and treatment (b) groups.
Figure 3A comparison of the first and third observations between the control (a) and treatment (b) groups.